ABSTRACT Patch testing is considered safe in the evaluation of selected non‐immediate drug hypersensitivity reactions in both children and adults. This report describes a 2‐year‐7‐month‐old boy whose index reaction to amoxicillin–clavulanate was a non‐severe but widespread maculopapular eruption that intensified with continued dosing. Because of its extent and progression, patch testing was performed before the planned drug provocation test. A disseminated maculopapular eruption developed after patch testing, with a strong positive (2+) reaction at 48 h. This case highlights that generalized cutaneous reactions may rarely occur after patch testing, even when the initial reaction is non‐severe.
Cansu Türkay, Sezin Aydemir, Leman Tuba Karakurt, Mustafa Arga. A Disseminated Adverse Drug Reaction in a Child in Response to Beta‐Lactam Patch Testing. // Pediatric Dermatology. – 2026. – DOI: 10.1111/pde.70399. – URL: https://onlinelibrary.wiley.com/doi/10.1111/pde.70399?af=R
Cansu Türkay, Sezin Aydemir, Leman Tuba Karakurt, & Mustafa Arga (2026). A Disseminated Adverse Drug Reaction in a Child in Response to Beta‐Lactam Patch Testing. Pediatric Dermatology. https://doi.org/10.1111/pde.70399
Cansu Türkay, et al. “A Disseminated Adverse Drug Reaction in a Child in Response to Beta‐Lactam Patch Testing.” Pediatric Dermatology, 2026. doi:10.1111/pde.70399.
@article{Trkay2026,
title = {A Disseminated Adverse Drug Reaction in a Child in Response to Beta‐Lactam Patch Testing},
author = {Türkay, Cansu and Aydemir, Sezin and Karakurt, Leman Tuba and Arga, Mustafa},
journal = {Pediatric Dermatology},
year = {2026},
doi = {10.1111/pde.70399},
url = {https://onlinelibrary.wiley.com/doi/10.1111/pde.70399?af=R}
}